| Literature DB >> 22906773 |
Abstract
Corticosteroids and, according to severity or vasculitis type, cytotoxic agents are prescribed to treat systemic necrotizing vasculitides. Usually, in most vasculitides, treatment is prescribed for at least 18 months. Treatment is able to obtain a remission in approximatively 90% of patients. Relapse rate is high. Cyclophosphamide is usually prescribed for a few months, and administered by pulses. A maintenance treatment is compulsory and comprises usually azathioprine and methotrexate. Biologics can be proposed as ad on therapy like intravenous immunoglobulins and anti-TNF. Rituximab, an anti-CD20 drug is as effective as cyclophosphamide. It can be also prescribed to maintain remission.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22906773 DOI: 10.1016/j.lpm.2012.06.008
Source DB: PubMed Journal: Presse Med ISSN: 0755-4982 Impact factor: 1.228